Efficacy and Adverse Events of Platelet Transfusion – Product-Specific Differences
- 1 January 2008
- journal article
- Published by S. Karger AG in Transfusion Medicine and Hemotherapy
- Vol. 35 (2) , 102-105
Abstract
Two preparations are available for platelet transfusion: single-donor apheresis platelet concentrates (APC) and pooled platelet concentrates (PPC) prepared from 4–6 whole blood units. Clear advantages of APC over PPC are a markedly reduced donor exposure of recipients, and easier logistics when attempting a complete supply with ABO-identical and Rh-compatible platelet concentrates. Regulations should aim at complete ABO-identical platelet transfusions because major and minor ABO-incompatible platelet transfusions are probably associated with significantly increased morbidity and mortality. The main advantage of PPC is lower costs. Preparation of PPC is however inevitably accompanied by substantial wastage of plasma and red cells. Only major supraregional blood transfusion centers can guarantee full-coverage supply with ABO-identical and Rh-compatible PPC. Whether APC are more effective than PPC and associated with fewer septic platelet transfusion reactions as shown in some but not all studies, has to be examined in future prospective controlled trials.Keywords
This publication has 40 references indexed in Scilit:
- Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantationBone Marrow Transplantation, 2007
- Factors affecting platelet yield and their impact on the platelet increment of patients receiving single donor PLT transfusionJournal of Clinical Apheresis, 2007
- Logistics of platelet concentratesesVox Sanguinis, 2006
- In vivo recovery and survival of apheresis and whole blood‐derived platelets: a paired comparison in healthy volunteersTransfusion, 2006
- Platelet Transfusion Containing ABO-Incompatible Plasma and Hepatic Veno-occlusive Disease after Hematopoietic Transplantation in Young ChildrenTransplantation, 2005
- Absence of anti‐D alloimmunization in hematologic patients after D‐incompatible platelet transfusionsTransfusion, 2002
- Paired in vivo and in vitro comparison of apheresis and “recovered” platelet concentrates stored for 5 daysJournal of Clinical Apheresis, 1994
- ABO and platelet transfusion revisitedAnnals of Hematology, 1993
- Alloimmunization to RhD by Platelet Transfusions in Autologous Bone Marrow Transplant RecipientsVox Sanguinis, 1990
- ABO compatibility can influence the results of platelet transfusionTransfusion, 1989